UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
OPERATING ACTIVITIES
Net income including non-controlling interest	$ 11,427	$ 11,982
Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:
Depreciation and amortization	3,788	3,824
Provision for credit losses	1,512	1,305
Equity-based awards compensation expense	1,806	1,846
Deferred income taxes	221	2,132
Change in revaluation of put-right liability	149	(603)
Change in fair value of contingent earn-out consideration	698	0
Earnings in unconsolidated affiliate	(274)	(339)
Other	125	93
Changes in operating assets and liabilities:
Increase in patient accounts receivable	(5,999)	(4,676)
Increase in accounts receivable - other	(796)	(2,145)
Increase (decrease) in other assets	1,897	(735)
(Decrease ) increase in accounts payable and accrued expenses	(1,846)	1,445
Decrease in other long-term liabilities	(1,359)	(2,480)
Net cash provided by operating activities	11,349	11,649
INVESTING ACTIVITIES
Purchase of fixed assets	(2,059)	(2,528)
Purchase of majority interest in businesses, net of cash acquired	(5,796)	(11,242)
Purchase of redeemable non-controlling interest, temporary equity	(5,178)	(2,211)
Purchase of non controlling interest-permanent	0	(99)
Proceeds on sale of partnership interest - redeemable non-controlling interest	107	4
Distributions from unconsolidated affiliate	245	132
Net cash used in investing activities	(12,681)	(15,944)
FINANCING ACTIVITIES
Distributions to non-controlling interest, permanent and temporary equity	(3,297)	(3,711)
Proceeds from revolving line of credit	7,000	35,000
Proceeds from term loan	0	(31,000)
Payments on term loan	(938)	0
Principal payments on notes payable	(422)	(332)
Net cash provided by (used in) financing activities	2,343	(43)
Net increase (decrease) in cash and cash equivalents	1,011	(4,338)
Cash and cash equivalents - beginning of period	31,594	28,567	$ 28,567
Cash and cash equivalents - end of period	32,605	24,229	$ 31,594
Cash paid during the period for:
Income taxes	442	81
Interest paid	1,377	525
Non-cash investing and financing transactions during the period:
Purchase of businesses - seller financing portion	360	300
Notes payable related to purchase of redeemable non-controlling interest, temporary equity	611	246
Notes payable related to purchase of non-controlling interest, permanent equity	0	296
Notes receivable related to sale of partnership interest - redeemable non-controlling interest	532	0
Dividends payable to USPH shareholders	$ 5,617	$ 5,327